🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

THC THC

Company Profile ↓
$261.74
+65.56% 1Y
Mkt Cap$41.52B
P/E16.90
P/B9.84
52W High$262.63
52W Low$158.09
Book Value$26.61
EPS (TTM)$15.49

Company Overview

THC (THC) is a publicly traded company listed on with a market capitalization of $41.52B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 33.3%, reflecting efficient use of shareholder capital.

Consistent Profit Growth

Net profit has compounded at 28.6% per year over the last five years.

Reasonable Valuation

Trades at an undemanding P/E of 16.9.

Healthy Margins

Operating margin of 16.1% supports profitability.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $21.31B (+3.1% YoY); net profit $1.41B.
  • Trailing 12 Months Year-on-year growth — revenue +3.1%, earnings -56.0%.
  • 5-Year Trend Long-term compounding — revenue CAGR 0.1%, profit CAGR 28.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:0.14%
1 Year:3.07%

Compounded Profit Growth

5 Years:28.65%
1 Year:-56.03%

Stock Price Performance

1 Year:+65.56%
6 Months:+35.72%
3 Months:+40.04%
1 Month:+25.34%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 99% of range
$158.09 $262.63
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)73.60 · Overbought
Price Performance
1M+25.34%
3M+40.04%
6M+35.72%
1Y+65.56%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Strong return on equity of 33.3%.
  • Profit CAGR of 28.6% over 5 years.
  • Generates positive free cash flow.

CONS

  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
16.90
Industry PE
-
Forward P/E est.
33.80
PEG Ratio
-
Book Value
$26.61
Price to Book
9.84
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
0.14%
Profit 5Y
28.65%
Revenue (YoY)
3.07%
Earnings (YoY)
-56.03%

Profitability & Returns

ROCE
13.64%
ROE
33.34%
ROA
4.74%
Profit Margin
6.60%
Op Margin
16.14%
Gross Margin
82.26%
EPS (Latest Qtr)
$9.84
EPS (TTM)
$15.49

Balance Sheet & Liquidity

Debt/Equity
3.12
Quick Ratio
1.68
Current Ratio
1.76
Debt
$13.17B
Total Assets
$30.68B
Current Assets
$7.83B
Working Capital
$3.39B

Ownership

Promoter Holding
1.15%
Chg in Prom Hold
-
FII / Inst Holding
105.15%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$21.31B
EBITDA
$4.48B
Free Cash Flow
$2.53B
Operating Cash Flow
$3.54B
Shares Outstanding
158.61M
Gross Margin
82.26%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue -------5.17B4.94B-----4.54B4.56B4.57B4.81B4.52B3.65B4.56B4.92B4.78B4.95B4.89B4.75B4.64B4.80B5.02B5.08B5.07B5.37B5.11B5.13B-5.27B5.29B5.53B5.78B6.04B
Cost of Revenue -----------------------------------932.00M931.00M1.01B961.00M984.00M
Gross Profit -----------------------------------4.34B4.36B4.52B4.82B5.06B
Operating Expenses -----------------------------------3.49B3.54B3.65B3.52B3.62B
Operating Income 290.00M164.00M287.00M354.00M274.00M339.00M267.00M310.00M51.00M-517.00M406.00M320.00M-381.00M400.00M302.00M-327.00M471.00M271.00M-520.00M586.00M1.01B648.00M553.00M596.00M603.00M604.00M568.00M3.29B761.00M1.09B-852.00M817.00M869.00M1.29B1.44B
EBITDA -----------------------------------1.06B1.14B1.12B1.57B1.76B
Interest Expense -----------------------------------206.00M206.00M205.00M205.00M204.00M
Pretax Income -----------------------------------642.00M712.00M681.00M1.13B1.34B
Tax Provision -----------------------------------120.00M133.00M37.00M226.00M295.00M
Net Income -----------------------------------288.00M342.00M371.00M702.00M826.00M
Diluted EPS 0.47-0.61-0.29-0.60-0.46-0.08-0.53-0.55-3.64-2.270.960.25-0.09-0.04-0.110.25-2.18-0.030.880.83-1.863.860.901.104.131.280.351.161.321.150.9421.382.644.89-3.143.864.228.019.84

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue --------21.07B20.61B18.31B18.48B17.64B-19.17B20.56B20.68B21.31B
Cost of Revenue --------------3.27B3.59B3.65B3.78B
Gross Profit --------------15.90B16.97B17.03B17.53B
Operating Expenses --------------13.49B14.53B14.11B14.09B
Operating Income 311.00M538.00M634.00M653.00M749.00M663.00M925.00M1.08B1.25B1.11B1.64B1.54B1.99B-2.41B2.44B2.92B3.44B
EBITDA --------------3.08B3.39B6.89B4.48B
Interest Expense --------------890.00M901.00M826.00M821.00M
Pretax Income --------------1.34B1.62B5.25B2.80B
Tax Provision --------------344.00M306.00M1.18B433.00M
Net Income 25.00M181.00M1.12B58.00M141.00M-134.00M12.00M-140.00M-192.00M-704.00M104.00M-215.00M399.00M-411.00M611.00M3.20B1.41B
Diluted EPS 0.050.378.160.481.30-1.320.12-1.41-1.93-7.001.00-2.083.75-3.795.7132.7015.49

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --7.95B8.50B8.46B9.04B16.45B17.95B23.68B24.70B23.39B22.43B23.36B27.11B-27.16B28.31B28.94B29.68B
Current Assets ---------------5.98B7.17B7.68B7.85B
Cash & Equivalents 572.00M507.00M690.00M405.00M113.00M364.00M113.00M193.00M356.00M716.00M611.00M411.00M262.00M2.45B-858.00M1.23B3.02B2.88B
Inventory ---------------405.00M411.00M346.00M348.00M
Receivables ---------------2.94B2.91B2.54B2.56B
Total Liabilities --7.26B6.68B6.95B7.81B15.23B16.77B20.46B21.23B20.98B20.30B21.42B24.22B-22.55B22.80B20.39B20.70B
Current Liabilities --1.78B1.73B1.81B1.76B3.09B3.58B4.31B4.03B4.33B3.86B4.21B4.85B-4.48B4.76B4.31B4.46B
Long Term Debt ---------------14.93B14.88B13.08B13.09B
Total Debt ---------------15.08B15.00B13.17B13.17B
Total Equity 88.00M147.00M646.00M1.77B1.42B1.14B755.00M651.00M691.00M417.00M-147.00M-119.00M-417.00M28.00M-1.14B1.61B4.17B4.22B
Shares Outstanding ---------------156.46M157.27M158.00M158.61M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 208.00M425.00M472.00M497.00M593.00M589.00M687.00M1.03B558.00M1.20B1.05B1.23B3.41B-1.08B2.37B2.05B3.54B
Investing Cash Flow -274.00M-125.00M-420.00M-503.00M-662.00M-2.16B-1.32B-1.32B-430.00M21.00M-115.00M-619.00M-1.61B--808.00M-969.00M3.43B-1.27B
Financing Cash Flow 1.00M-117.00M-337.00M-286.00M320.00M1.32B715.00M454.00M232.00M-1.33B-1.13B-763.00M385.00M-936.00M-1.78B-1.03B-3.69B-
Capital Expenditure ----467.00M-506.00M-691.00M-933.00M-842.00M-875.00M-707.00M-617.00M-670.00M-540.00M--762.00M-751.00M-931.00M-1.01B
Free Cash Flow ---30.00M87.00M-102.00M-246.00M184.00M-317.00M493.00M432.00M563.00M2.87B-321.00M1.62B1.12B2.53B
Net Change in Cash ---------------1.51B370.00M1.79B-136.00M
Share Buybacks -00374.00M126.00M400.00M-40.00M00--00250.00M200.00M672.00M1.39B

Ratios (Annual)

Figures in %.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % --------------82.9%82.5%82.4%82.3%
Operating Margin % --------5.9%5.4%8.9%8.3%11.3%-12.6%11.9%14.1%16.1%
Net Margin % ---------0.9%-3.4%0.6%-1.2%2.3%-2.1%3.0%15.5%6.6%
ROE % 17.0%28.0%63.4%4.1%12.3%-17.7%1.8%-20.3%-46.0%478.9%-87.4%51.6%1,425.0%-36.0%38.0%76.7%33.3%
ROCE % -8.7%9.4%9.8%10.3%5.0%6.4%5.6%6.0%5.8%8.8%8.0%8.9%-10.6%10.4%11.8%13.6%

Shareholding Pattern

Insiders
1.15%
Institutions
105.15%
Public Float
106.37%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for THC

Yahoo Finance ue, 04 Aug 2026

Is It Worth Investing in Tenet (THC) Based on Wall Street's Bullish Views?

The average brokerage recommendation (ABR) for Tenet (THC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying …

Yahoo Finance ue, 04 Aug 2026

INTX Introduces Tenet, the Industry's First Native Intelligence Layer for the (Re)Insurance Operating System

AUSTIN, Texas, August 04, 2026--INTX Insurance Software today introduced Tenet, the industry's first native Intelligence Layer for the (Re)Insurance Operating System. Embedded directly within the unified INTX platform, Tenet brings contextu…

Yahoo Finance ue, 04 Aug 2026

Fast-paced Momentum Stock Tenet (THC) Is Still Trading at a Bargain

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Tenet (THC) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Barga…

Yahoo Finance ue, 04 Aug 2026

Tenet Provides Update on July Sales and 2026 Revenue Guidance

Toronto, Ontario--(Newsfile Corp. - August 4, 2026) - Tenet Fintech Group Inc. (CSE: PKK) (OTC Pink: PKKFF) ("Tenet" or the "Company"), an innovative analytics service provider, owner and operator of the Cubeler Business Hub, today announce…

Yahoo Finance Mon, 03 Aug 2026

Tenet Healthcare (THC) Stock Still Looks Cheap On Earnings

Tenet Healthcare has delivered a very strong 270.6% return over the past 5 years, so the key issue for investors now is whether the current price still lines up with what the valuation checks suggest about the stock. The 270.6% 5 year retur…

Yahoo Finance Mon, 03 Aug 2026

Can Higher Occupancy Help Encompass Health Counter Rising Costs in Q2?

EHC's higher occupancy, rising discharges and hospital expansion could support Q2 growth, but can they offset mounting operating costs?

THC — Frequently Asked Questions

What is the current share price of THC?

As of 2026-08-05 17:25 PDT, THC trades at $261.74 on NASDAQ/NYSE. Its 52-week range is $158.09 to $262.63.

What is the market capitalisation of THC?

THC has a market capitalisation of $41.52B on NASDAQ/NYSE.

What is the P/E ratio of THC?

THC trades at a trailing price-to-earnings (P/E) ratio of 16.90. Its price-to-book (P/B) ratio is 9.84.

What is the return on equity (ROE) of THC?

THC has a return on equity (ROE) of 33.34%. Its return on capital employed (ROCE) is 13.64%.

Is THC a good stock to buy?

This page provides a data-driven analysis of THC, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space